Vanguard Group
NVNO

Vanguard Group’s enVVeno Medical NVNO Stock Holding History

Vanguard Group’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$96.1K Sell
8,550
-16,055
-65% -$312K ﹤0.01% 4183
2025
Q3 		$780K Buy
24,605
+4,652
+23% +$475K ﹤0.01% 3853
2025
Q2 		$2.79M Buy
19,953
+2,784
+16% +$329K ﹤0.01% 3412
2025
Q1 		$1.58M Buy
17,169
+336
+2% +$37.4K ﹤0.01% 3568
2024
Q4 		$1.78M Hold
16,833
– – ﹤0.01% 3600
2024
Q3 		$1.98M Hold
16,833
– – ﹤0.01% 3562
2024
Q2 		$3.09M Buy
16,833
+434
+3% +$75.8K ﹤0.01% 3424
2024
Q1 		$3.12M Buy
16,399
+6,787
+71% +$1.22M ﹤0.01% 3451
2023
Q4 		$1.73M Buy
9,612
+18
+0.2% +$2.87K ﹤0.01% 3653
2023
Q3 		$1.81M Hold
9,594
– – ﹤0.01% 3623
2023
Q2 		$1.03M Hold
9,594
– – ﹤0.01% 3888
2023
Q1 		$1.57M Hold
9,594
– – ﹤0.01% 3765
2022
Q4 		$1.71M Buy
9,594
+5
+0.1% +$1.02K ﹤0.01% 3719
2022
Q3 		$2.11M Hold
9,589
– – ﹤0.01% 3716
2022
Q2 		$1.27M Buy
9,589
+1,624
+20% +$252K ﹤0.01% 4007
2022
Q1 		$1.78M Hold
7,965
– – ﹤0.01% 4003
2021
Q4 		$1.84M Buy
7,965
+240
+3% +$67.6K ﹤0.01% 4076
2021
Q3 		$2.81M Buy
7,725
+334
+5% +$86.5K ﹤0.01% 3942
2021
Q2 		$1.78M Buy
7,391
+6,125
+484% +$1.32M ﹤0.01% 3997
2021
Q1 		$295K Buy
1,266
+764
+152% +$213K ﹤0.01% 4211
2020
Q4 		$152K Buy
+502
New +$156K ﹤0.01% 4111
2019
Q4 		– Sell
-69
Closed -$52K – 4133
2019
Q3 		$52K Sell
69
-100
-59% -$86.9K ﹤0.01% 4082
2019
Q2 		$154K Buy
169
+3
+2% +$4.74K ﹤0.01% 4008
2019
Q1 		$227K Buy
166
+2
+1% +$2.9K ﹤0.01% 3898
2018
Q4 		$202K Buy
164
+104
+173% +$187K ﹤0.01% 3900
2018
Q3 		$141K Buy
+60
New +$139K ﹤0.01% 4045

Other funds holding NVNO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM

Vanguard Group's NVNO Position: Q4 2025 in Review

Vanguard Group reduced its enVVeno Medical (NVNO) stake by 65% in Q4 2025, selling an estimated $312K and leaving 8,550 shares worth $96.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4183.

Vanguard Group first reported a position in NVNO in Q3 2018 and has held it in 26 quarters since. The position peaked at $3.12M in Q1 2024. 36 funds tracked by Wall St. Rank hold NVNO as of Q4 2025.

  • Vanguard Group held 8,550 shares of enVVeno Medical worth $96.1K as of Q4 2025.
  • Vanguard Group sold 16,055 enVVeno Medical shares in Q4 2025, an estimated $312K.
  • enVVeno Medical made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4183 holding.
  • Vanguard Group first reported a position in enVVeno Medical in Q3 2018 and has held it in 26 quarters since.
  • Vanguard Group's enVVeno Medical position peaked at $3.12M in Q1 2024.
  • 36 funds tracked by Wall St. Rank held enVVeno Medical as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.